​

Funding Round

Private Equity Round - ProtaGene

Private Equity Round - ProtaGene

Investment Firm

Overview

ProtaGene is a CRO partner for the biopharmaceutical, cell, and gene therapy industries.

Announced Date

Nov 20, 2023

Funding Type

Private Equity

Highlights

Location

Europe

Social

Investor Lead

Ampersand Capital Partners

Ampersand Capital Partners

Ampersand Capital Partners is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorAmpersand Capital Partners

Round Details and Background

ProtaGene raised an undisclosed amount on 2023-11-20 in Private Equity Round

ProtaGene is a CRO partner for the biopharmaceutical, cell, and gene therapy industries.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 20, 2023
Private Equity Round - ProtaGene
1-undefined

Recent Activity

There is no recent news or activity for this profile.